
Venture capital · Early stage · Est. 2000
Aisling Capital
New York-based life sciences investment firm that backs healthcare product, service and technology companies across private and public markets, active since 2000.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Aisling Capital right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
Rounds Aisling Capital joined, from press and the firm’s own posts.
Every round Aisling Capital joined
Round sizes, Aisling Capital’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company Aisling Capital backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Aisling Capital
Events where Aisling Capital’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Aisling Capital is based in New York, United States.
In 2000.
2 fund vehicles are on public registers (SEC adviser filings), including AISLING CAPITAL II, LP and AISLING CAPITAL III, LP.
Stages: Seed, Buyout. Sectors: Life sciences, Biotech. From the firm’s own website.
Aisling looks for differentiated healthcare products, services and technologies addressing unmet medical needs, entering when capital and strategic help can most improve a company's odds. It underwrites scientific, regulatory, financial and commercial risk and works actively with management on strategy and exits. From the firm’s own website.
Aisling Capital lists 99 portfolio companies on its website, including Aclaris Therapeutics, Inc., Adams Respiratory Therapeutics, Inc., ADMA Biologics, Inc., Advion, Inc. and Aeglea BioTherapeutics, Inc..
Firms whose websites list some of the same companies include Foresite Capital, RA Capital and HealthCap.
Know before Aisling Capital’s next round is announced.
PRO tracks Aisling Capital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.